Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Angiodynamics Inc (ANGO)  
$5.79 0.03 (0.52%) as of 4:30 Tue 4/30


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 38,650,000
Market Cap: 223.78(M)
Last Volume: 381,024 Avg Vol: 353,730
52 Week Range: $5.27 - $11.16
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:

    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    : 6.2
Insider 6 Months    : 6.2
Insider 3/6 Months : 12.8
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   AngioDynamics designs, manufactures and sells a range of medical, surgical and diagnostic devices used by healthcare providers. Co.'s product offerings fall within three Global Business Units: Endovascular Therapies, Oncology/Surgery and Vascular Access. Co.'s technology products including auryon, the thrombectomy platform (which includes AngioVac, AlphaVac and thrombolytics) and nanoknife. Co.'s Peripheral Products include angiographic products and accessories, drainage products, and micro access kits. Co. provides a variety of dialysis catheters, including: BioFlo DuraMax, which is a dialysis catheter with Endexo Technology; and DuraMax, which is a stepped-tip catheter.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 10,000 10,000 10,000 21,083
Total Buy Value $67,000 $67,000 $67,000 $231,967
Total People Bought 1 1 1 2
Total Buy Transactions 1 1 1 3
Total Shares Sold 0 0 0 9,633
Total Sell Value $0 $0 $0 $172,197
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 2
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 472
  Page 9 of 19  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Auen Eileen Oshea Director   –       •      –    2020-07-14 4 A $0.00 $0 D/D 15,323 36,663     -
   Donnelly Howard W Director   –       •      –    2020-07-14 4 A $0.00 $0 D/D 15,323 90,869     -
   Campbell Chad Thomas SVP/GM, Vascular Access   •       –      –    2020-05-23 4 D $11.21 $9,259 D/D (826) 18,102     -
   Clemmer James C President and CEO   •       •      –    2020-04-04 4 D $10.23 $43,426 D/D (4,245) 256,173     -
   Boucher Brent J. SVP and GM of Oncology   •       –      –    2020-02-12 4 D $12.99 $6,365 D/D (490) 15,416     -
   Trowbridge Stephen A EVP, General Counsel and CFO   •       –      –    2020-02-03 4 A $0.00 $0 D/D 5,376 45,499     -
   Helsel Dave SVP Global Operations and R&D   •       –      –    2019-12-18 4 D $15.57 $11,460 D/D (736) 16,422     -
   Clemmer James C President and CEO   •       •      –    2019-10-25 4 B $14.19 $212,850 D/D 15,000 260,418 2.81     -
   Greiner Michael EVP and CFO   •       –      –    2019-08-18 4 D $19.10 $15,777 D/D (826) 33,438     -
   Johnson Wesley Director   –       •      –    2019-08-06 4 D $19.83 $71,011 D/D (3,581) 69,088     -
   Johnson Wesley Director   –       •      –    2019-08-06 4 OE $10.68 $71,022 D/D 6,650 72,669     -
   Campbell Chad Thomas SVP/GM, Vascular Access   •       –      –    2019-07-27 4 D $20.91 $5,269 D/D (252) 18,928     -
   Clemmer James C President and CEO   •       •      –    2019-07-27 4 D $20.91 $36,634 D/D (1,752) 141,558     -
   Trowbridge Stephen A SVP and General Counsel   •       –      –    2019-07-27 4 D $20.91 $5,959 D/D (285) 37,723     -
   Campbell Chad Thomas SVP/GM, Vascular Access   •       –      –    2019-07-26 4 D $20.89 $5,766 D/D (276) 19,180     -
   Clemmer James C President and CEO   •       •      –    2019-07-26 4 D $20.89 $38,145 D/D (1,826) 143,310     -
   Greiner Michael EVP and CFO   •       –      –    2019-07-26 4 D $20.89 $10,675 D/D (511) 27,304     -
   Simpson Robert Arthur SVP/GM, Global Vascular   •       –      –    2019-07-26 4 D $20.89 $6,455 D/D (309) 15,441     -
   Trowbridge Stephen A SVP and General Counsel   •       –      –    2019-07-26 4 D $20.89 $6,392 D/D (306) 38,008     -
   Trowbridge Stephen A SVP and General Counsel   •       –      –    2019-07-22 4 D $21.38 $7,590 D/D (355) 38,314     -
   Trowbridge Stephen A SVP and General Counsel   •       –      –    2019-07-22 4 D $21.38 $7,590 D/D (355) 38,669     -
   Campbell Chad Thomas SVP/GM, Vascular Access   •       –      –    2019-07-18 4 D $21.53 $6,287 D/D (292) 19,456     -
   Helsel Dave SVP Global Operations and R&D   •       –      –    2019-07-18 4 D $21.53 $8,720 D/D (405) 17,158     -
   Trowbridge Stephen A SVP and General Counsel   •       –      –    2019-07-18 4 D $21.53 $8,375 D/D (389) 39,024     -
   Clemmer James C President and CEO   •       •      –    2019-07-18 4 D $21.53 $31,089 D/D (1,444) 145,136     -

  472 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 19
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed